Core Insights - The pharmaceutical logistics industry is experiencing robust growth driven by national policy support, an aging population, increased health awareness, and advancements in medical technology. The "Healthy China" strategy is further enhancing the industry's development space [1][7][9]. Industry Overview - Pharmaceutical logistics is a crucial component of modern logistics, responsible for the circulation and turnover of pharmaceuticals. It encompasses seven main functions: transportation and distribution, warehousing management, packaging, circulation processing, loading and unloading, network design, and information processing [2][5][7]. Market Growth - The total value of pharmaceutical logistics in China has shown steady growth, increasing from 241.86 billion yuan in 2019 to an expected 336.66 billion yuan in 2024, with a compound annual growth rate (CAGR) of 6.84%. Projections indicate that this total will reach 357.2 billion yuan by 2025 [1][4][9]. Sales Growth of Pharmaceutical Products - The total sales of seven major categories of pharmaceutical products in China rose from 1,661.3 billion yuan in 2015 to an estimated 2,947.0 billion yuan in 2024, reflecting a CAGR of 6.58%. This expanding market size supports the demand for pharmaceutical logistics [4][9]. Industry Structure - The pharmaceutical logistics industry consists of three main segments: upstream (pharmaceutical manufacturers and equipment suppliers), midstream (logistics companies), and downstream (medical institutions, pharmacies, and patients) [5][6]. Logistics Centers and Warehousing - The number of logistics centers in the pharmaceutical logistics industry increased from 1,115 in 2017 to 1,370 in 2024, with a CAGR of 2.99%. Warehouse area expanded from 10.65 million square meters to 15.42 million square meters during the same period, with a CAGR of 5.43% [10][11]. Transportation Vehicles - The total number of specialized transportation vehicles in the pharmaceutical logistics sector is projected to reach 17,617 by 2024, with refrigerated vehicles accounting for 19.9% of the total, indicating a growing demand for cold chain logistics [12][13]. Delivery Methods and Technology - In 2024, 62.5% of deliveries in the pharmaceutical logistics industry were self-delivered, while 37.5% were outsourced. The adoption of automation and information technology is increasing, with 89.0% of companies having warehouse management systems and 83.1% using electronic tagging systems [13][14]. Key Players - Major companies in the pharmaceutical logistics sector include JD Logistics, China National Pharmaceutical Group, and various specialized logistics firms. JD Logistics reported a revenue of 153.616 billion yuan in the first three quarters of 2025, reflecting a year-on-year growth of 17.5% [14][16]. Industry Challenges - Despite the growth, the pharmaceutical logistics industry faces challenges such as high overall costs, uneven regional development, and a lack of relevant standards [17]. Future Trends - The industry is expected to evolve towards greater automation and intelligence, with AI systems optimizing logistics operations. Additionally, a shift towards full traceability and data integration is anticipated, enhancing the efficiency and responsiveness of the logistics network [18][19].
研判2025!中国医药物流行业发展背景、产业链、发展现状、重点企业及前景展望分析:电商与互联网医疗兴起,带动医药物流总额增至3572亿元[图]